Sales | Number of Estimates | | | 14 | 21 | 20 | 18 | 10 | 5 |
Sales | Highest | | | 1,403.7 | 5,126.0 | 5,515.7 | 6,014.0 | 6,557.2 | 7,154.3 |
Sales | Consensus | 1,230.2 | 4,730.2 | 1,272.3 | 4,932.9 | 5,232.5 | 5,576.2 | 5,957.8 | 6,464.6 |
Sales | Median | | | 1,266.7 | 4,915.0 | 5,212.5 | 5,571.5 | 5,937.0 | 6,300.0 |
Sales | Lowest | | | 1,191.0 | 4,797.2 | 5,074.6 | 5,374.8 | 5,687.4 | 6,214.0 |
Price/Volume (%) | Number of Estimates | | | 13 | 16 | 15 | 15 | 10 | 5 |
Price/Volume (%) | Highest | | | 14.5 | 9.7 | 7.7 | 6.7 | 6.7 | 6.6 |
Price/Volume (%) | Consensus | 10.6 | 7.9 | 9.1 | 7.1 | 6.1 | 6.2 | 6.2 | 6.2 |
Price/Volume (%) | Median | | | 8.6 | 6.9 | 6.3 | 6.2 | 6.2 | 6.3 |
Price/Volume (%) | Lowest | | | 5.7 | 5.8 | 3.3 | 5.8 | 5.8 | 6.0 |
M&A (%) | Number of Estimates | | | 12 | 14 | 13 | 13 | 9 | 5 |
M&A (%) | Highest | | | 0.0 | 0.0 | 2.7 | 2.7 | 2.7 | 2.7 |
M&A (%) | Consensus | 2.3 | 0.8 | -0.2 | -0.3 | 0.1 | 0.2 | 0.4 | 0.5 |
M&A (%) | Median | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
M&A (%) | Lowest | | | -0.8 | -0.8 | -0.8 | 0.0 | 0.0 | 0.0 |
FX (%) | Number of Estimates | | | 12 | 14 | 13 | 13 | 9 | 5 |
FX (%) | Highest | | | -0.4 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
FX (%) | Consensus | -0.1 | -6.3 | -5.2 | -2.8 | 0.0 | 0.0 | 0.0 | 0.0 |
FX (%) | Median | | | -5.6 | -2.6 | 0.0 | 0.0 | 0.0 | 0.0 |
FX (%) | Lowest | | | -9.7 | -5.5 | -0.2 | 0.0 | 0.0 | 0.0 |
EBITDA normalized* | Number of Estimates | | | - | 22 | 21 | 18 | 9 | 4 |
EBITDA normalized* | Highest | | | - | 1,033.0 | 1,158.4 | 1,281.1 | 1,419.4 | 1,570.1 |
EBITDA normalized* | Consensus | - | 903.5 | - | 1,000.3 | 1,090.6 | 1,183.4 | 1,293.8 | 1,398.3 |
EBITDA normalized* | Median | | | - | 1,003.5 | 1,097.0 | 1,184.0 | 1,276.0 | 1,363.1 |
EBITDA normalized* | Lowest | | | - | 962.1 | 1,037.9 | 1,114.8 | 1,223.0 | 1,296.7 |
EBITDA-margin (%) normalized* | Number of Estimates | | | - | 21 | 20 | 18 | 9 | 4 |
EBITDA-margin (%) normalized* | Highest | | | - | 20.8 | 21.6 | 22.1 | 22.5 | 22.0 |
EBITDA-margin (%) normalized* | Consensus | - | 19.1 | - | 20.3 | 20.8 | 21.2 | 21.7 | 21.5 |
EBITDA-margin (%) normalized* | Median | | | - | 20.3 | 20.9 | 21.3 | 21.8 | 21.7 |
EBITDA-margin (%) normalized* | Lowest | | | - | 19.3 | 19.6 | 20.2 | 20.6 | 20.6 |
EBITDA reported | Number of Estimates | | | - | 22 | 21 | 18 | 9 | 4 |
EBITDA reported | Highest | | | - | 1,033.0 | 1,158.4 | 1,281.1 | 1,419.4 | 1,570.1 |
EBITDA reported | Consensus | - | 851.7 | - | 999.7 | 1,090.6 | 1,183.4 | 1,293.8 | 1,398.3 |
EBITDA reported | Median | | | - | 1,002.8 | 1,097.0 | 1,184.0 | 1,276.0 | 1,363.1 |
EBITDA reported | Lowest | | | - | 962.1 | 1,037.9 | 1,114.8 | 1,223.0 | 1,296.7 |
EBITDA-margin (%) reported | Number of Estimates | | | - | 21 | 20 | 18 | 9 | 4 |
EBITDA-margin (%) reported | Highest | | | - | 20.8 | 21.6 | 22.1 | 22.5 | 22.0 |
EBITDA-margin (%) reported | Consensus | - | 18.0 | - | 20.3 | 20.8 | 21.2 | 21.7 | 21.5 |
EBITDA-margin (%) reported | Median | | | - | 20.3 | 20.9 | 21.3 | 21.8 | 21.7 |
EBITDA-margin (%) reported | Lowest | | | - | 19.3 | 19.6 | 20.2 | 20.6 | 20.6 |
EBIT reported | Number of Estimates | | | - | 21 | 20 | 18 | 9 | 4 |
EBIT reported | Highest | | | - | 763.0 | 852.0 | 955.0 | 1,086.2 | 1,207.4 |
EBIT reported | Consensus | - | 559.4 | - | 703.3 | 787.7 | 876.7 | 971.8 | 1,039.9 |
EBIT reported | Median | | | - | 701.8 | 791.4 | 875.5 | 961.0 | 1,020.4 |
EBIT reported | Lowest | | | - | 677.1 | 714.9 | 800.7 | 859.6 | 911.3 |
EBIT-margin (%) reported | Number of Estimates | | | - | 20 | 19 | 18 | 9 | 4 |
EBIT-margin (%) reported | Highest | | | - | 15.3 | 16.2 | 16.8 | 17.4 | 16.9 |
EBIT-margin (%) reported | Consensus | - | 11.8 | - | 14.2 | 15.0 | 15.7 | 16.3 | 16.0 |
EBIT-margin (%) reported | Median | | | - | 14.3 | 15.0 | 15.8 | 16.6 | 16.2 |
EBIT-margin (%) reported | Lowest | | | - | 13.2 | 13.5 | 14.3 | 14.5 | 14.5 |
Profit before tax | Number of Estimates | | | - | 20 | 19 | 17 | 9 | 4 |
Profit before tax | Highest | | | - | 664.0 | 756.0 | 852.2 | 992.9 | 1,081.4 |
Profit before tax | Consensus | - | 464.9 | - | 605.9 | 692.2 | 798.8 | 900.9 | 969.2 |
Profit before tax | Median | | | - | 602.5 | 701.0 | 797.0 | 886.0 | 977.0 |
Profit before tax | Lowest | | | - | 567.0 | 581.0 | 730.7 | 789.6 | 841.3 |
Reported Income for the year | Number of Estimates | | | - | 22 | 21 | 18 | 9 | 4 |
Reported Income for the year | Highest | | | - | 487.0 | 555.0 | 626.2 | 722.2 | 795.7 |
Reported Income for the year | Consensus | - | 340.5 | - | 447.9 | 512.4 | 584.8 | 658.7 | 711.9 |
Reported Income for the year | Median | | | - | 446.3 | 513.0 | 587.5 | 650.9 | 718.7 |
Reported Income for the year | Lowest | | | - | 414.4 | 455.7 | 533.7 | 576.7 | 614.5 |
Average number of shares (in million) | Number of Estimates | | | - | 24 | 24 | 24 | 24 | 22 |
Average number of shares (in million) | Highest | | | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 |
Average number of shares (in million) | Consensus | - | 139.77 | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 |
Average number of shares (in million) | Median | | | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 |
Average number of shares (in million) | Lowest | | | - | 139.77 | 139.77 | 139.77 | 139.77 | 139.77 |
EPS attributable to the shareholders of Symrise - basic reported | Number of Estimates | | | - | 22 | 21 | 18 | 9 | 4 |
EPS attributable to the shareholders of Symrise - basic reported | Highest | | | - | 3.48 | 3.97 | 4.48 | 5.17 | 5.69 |
EPS attributable to the shareholders of Symrise - basic reported | Consensus | - | 2.44 | - | 3.20 | 3.67 | 4.18 | 4.71 | 5.09 |
EPS attributable to the shareholders of Symrise - basic reported | Median | | | - | 3.19 | 3.67 | 4.20 | 4.66 | 5.14 |
EPS attributable to the shareholders of Symrise - basic reported | Lowest | | | - | 2.97 | 3.26 | 3.82 | 4.13 | 4.40 |
Dividend | Number of Estimates | | | - | 20 | 19 | 16 | 9 | 3 |
Dividend | Highest | | | - | 1.50 | 1.79 | 2.08 | 2.37 | 1.98 |
Dividend | Consensus | - | 1.10 | - | 1.23 | 1.35 | 1.50 | 1.67 | 1.69 |
Dividend | Median | | | - | 1.20 | 1.30 | 1.40 | 1.55 | 1.60 |
Dividend | Lowest | | | - | 1.09 | 1.13 | 1.25 | 1.30 | 1.50 |
Scent & Care, Sales | Number of Estimates | | | 14 | 15 | 13 | 13 | 7 | 3 |
Scent & Care, Sales | Highest | | | 533.4 | 1,939.0 | 2,037.1 | 2,216.9 | 2,405.5 | 2,612.6 |
Scent & Care, Sales | Consensus | 454.0 | 1,751.8 | 483.8 | 1,847.0 | 1,948.6 | 2,059.1 | 2,181.8 | 2,356.8 |
Scent & Care, Sales | Median | | | 480.1 | 1,840.0 | 1,933.0 | 2,030.0 | 2,132.7 | 2,229.3 |
Scent & Care, Sales | Lowest | | | 450.0 | 1,792.8 | 1,874.0 | 1,977.0 | 2,085.8 | 2,228.5 |
Scent & Care Price/Volume (%) | Number of Estimates | | | 13 | 13 | 11 | 11 | 7 | 3 |
Scent & Care Price/Volume (%) | Highest | | | 17.0 | 8.7 | 6.0 | 5.9 | 5.9 | 5.6 |
Scent & Care Price/Volume (%) | Consensus | 4.2 | 5.6 | 10.4 | 6.9 | 5.1 | 5.4 | 5.3 | 5.2 |
Scent & Care Price/Volume (%) | Median | | | 10.3 | 6.5 | 5.4 | 5.5 | 5.5 | 5.0 |
Scent & Care Price/Volume (%) | Lowest | | | 5.5 | 5.5 | 1.7 | 5.0 | 5.0 | 5.0 |
Scent & Care M&A (%) | Number of Estimates | | | 12 | 12 | 10 | 10 | 7 | 3 |
Scent & Care M&A (%) | Highest | | | 0.0 | 0.0 | 3.0 | 3.0 | 3.0 | 3.0 |
Scent & Care M&A (%) | Consensus | 3.5 | 0.9 | -0.1 | -0.2 | 0.2 | 0.4 | 0.5 | 1.0 |
Scent & Care M&A (%) | Median | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Scent & Care M&A (%) | Lowest | | | -1.0 | -1.4 | -1.2 | 0.0 | 0.0 | 0.0 |
Scent & Care FX (%) | Number of Estimates | | | 12 | 12 | 10 | 10 | 7 | 3 |
Scent & Care FX (%) | Highest | | | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Scent & Care FX (%) | Consensus | 0.6 | -3.7 | -3.3 | -1.7 | 0.0 | 0.0 | 0.0 | 0.0 |
Scent & Care FX (%) | Median | | | -3.6 | -1.6 | 0.0 | 0.0 | 0.0 | 0.0 |
Scent & Care FX (%) | Lowest | | | -6.5 | -2.9 | -0.1 | 0.0 | 0.0 | 0.0 |
Scent & Care, EBITDA normalized* | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Scent & Care, EBITDA normalized* | Highest | | | - | 346.0 | 381.6 | 428.0 | 463.9 | 510.2 |
Scent & Care, EBITDA normalized* | Consensus | - | 276.7 | - | 327.8 | 362.4 | 395.6 | 425.5 | 443.7 |
Scent & Care, EBITDA normalized* | Median | | | - | 327.3 | 364.0 | 397.2 | 427.4 | 419.8 |
Scent & Care, EBITDA normalized* | Lowest | | | - | 312.0 | 313.8 | 353.9 | 382.2 | 401.3 |
Scent & Care, EBITDA-margin (%) normalized* | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Scent & Care, EBITDA-margin (%) normalized* | Highest | | | - | 18.7 | 19.7 | 20.3 | 21.3 | 19.5 |
Scent & Care, EBITDA-margin (%) normalized* | Consensus | - | 15.8 | - | 17.8 | 18.6 | 19.2 | 19.5 | 18.8 |
Scent & Care, EBITDA-margin (%) normalized* | Median | | | - | 17.8 | 18.8 | 19.4 | 19.3 | 18.8 |
Scent & Care, EBITDA-margin (%) normalized* | Lowest | | | - | 16.5 | 16.3 | 17.5 | 18.0 | 18.0 |
Scent & Care, EBITDA reported | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Scent & Care, EBITDA reported | Highest | | | - | 346.0 | 381.6 | 428.0 | 463.9 | 510.2 |
Scent & Care, EBITDA reported | Consensus | - | 222.4 | - | 327.4 | 362.4 | 395.6 | 425.5 | 443.7 |
Scent & Care, EBITDA reported | Median | | | - | 327.3 | 364.0 | 397.2 | 427.4 | 419.8 |
Scent & Care, EBITDA reported | Lowest | | | - | 312.0 | 313.8 | 353.9 | 382.2 | 401.3 |
Scent & Care, EBITDA-margin (%) reported | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Scent & Care, EBITDA-margin (%) reported | Highest | | | - | 18.7 | 19.7 | 20.3 | 21.3 | 19.5 |
Scent & Care, EBITDA-margin (%) reported | Consensus | - | 12.7 | - | 17.7 | 18.6 | 19.2 | 19.5 | 18.8 |
Scent & Care, EBITDA-margin (%) reported | Median | | | - | 17.8 | 18.8 | 19.4 | 19.3 | 18.8 |
Scent & Care, EBITDA-margin (%) reported | Lowest | | | - | 16.5 | 16.3 | 17.5 | 18.0 | 18.0 |
Taste, Nutrition & Health, Sales | Number of Estimates | | | 14 | 15 | 13 | 13 | 7 | 3 |
Taste, Nutrition & Health, Sales | Highest | | | 870.3 | 3,232.0 | 3,478.6 | 3,797.1 | 4,151.8 | 4,541.7 |
Taste, Nutrition & Health, Sales | Consensus | 776.1 | 2,978.3 | 788.4 | 3,087.1 | 3,297.3 | 3,528.4 | 3,783.9 | 4,246.2 |
Taste, Nutrition & Health, Sales | Median | | | 788.0 | 3,075.0 | 3,281.0 | 3,506.0 | 3,747.2 | 4,126.7 |
Taste, Nutrition & Health, Sales | Lowest | | | 741.0 | 3,007.5 | 3,181.3 | 3,388.1 | 3,601.6 | 4,070.3 |
Taste, Nutrition & Health Price/Volume (%) | Number of Estimates | | | 13 | 13 | 11 | 11 | 7 | 3 |
Taste, Nutrition & Health Price/Volume (%) | Highest | | | 13.0 | 9.1 | 9.2 | 7.5 | 7.5 | 7.5 |
Taste, Nutrition & Health Price/Volume (%) | Consensus | 14.6 | 9.3 | 8.3 | 7.1 | 6.7 | 6.7 | 6.8 | 7.0 |
Taste, Nutrition & Health Price/Volume (%) | Median | | | 8.5 | 6.6 | 6.7 | 6.7 | 6.7 | 6.9 |
Taste, Nutrition & Health Price/Volume (%) | Lowest | | | 5.5 | 6.0 | 4.3 | 6.0 | 6.0 | 6.5 |
Taste, Nutrition & Health M&A (%) | Number of Estimates | | | 12 | 12 | 10 | 10 | 7 | 3 |
Taste, Nutrition & Health M&A (%) | Highest | | | 0.5 | 0.5 | 2.5 | 2.5 | 2.5 | 2.5 |
Taste, Nutrition & Health M&A (%) | Consensus | 1.5 | 0.7 | -0.2 | -0.4 | 0.1 | 0.3 | 0.4 | 0.8 |
Taste, Nutrition & Health M&A (%) | Median | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Taste, Nutrition & Health M&A (%) | Lowest | | | -1.3 | -1.3 | -1.3 | 0.0 | 0.0 | 0.0 |
Taste, Nutrition & Health FX (%) | Number of Estimates | | | 12 | 12 | 10 | 10 | 7 | 3 |
Taste, Nutrition & Health FX (%) | Highest | | | -0.9 | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 |
Taste, Nutrition & Health FX (%) | Consensus | -0.6 | -7.8 | -6.2 | -3.2 | 0.0 | 0.0 | 0.0 | 0.0 |
Taste, Nutrition & Health FX (%) | Median | | | -6.7 | -3.2 | 0.0 | 0.0 | 0.0 | 0.0 |
Taste, Nutrition & Health FX (%) | Lowest | | | -11.5 | -5.4 | -0.3 | 0.0 | 0.0 | 0.0 |
Taste, Nutrition & Health, EBITDA normalized* | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Taste, Nutrition & Health, EBITDA normalized* | Highest | | | - | 688.0 | 776.8 | 863.1 | 955.5 | 1,059.9 |
Taste, Nutrition & Health, EBITDA normalized* | Consensus | - | 626.8 | - | 673.7 | 734.4 | 796.0 | 867.5 | 964.6 |
Taste, Nutrition & Health, EBITDA normalized* | Median | | | - | 674.0 | 735.0 | 790.0 | 869.1 | 938.4 |
Taste, Nutrition & Health, EBITDA normalized* | Lowest | | | - | 653.2 | 693.9 | 735.5 | 779.6 | 895.5 |
Taste, Nutrition & Health, EBITDA-margin (%) normalized* | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Taste, Nutrition & Health, EBITDA-margin (%) normalized* | Highest | | | - | 22.4 | 23.4 | 24.0 | 24.6 | 23.3 |
Taste, Nutrition & Health, EBITDA-margin (%) normalized* | Consensus | - | 21.0 | - | 21.8 | 22.3 | 22.6 | 22.9 | 22.7 |
Taste, Nutrition & Health, EBITDA-margin (%) normalized* | Median | | | - | 21.8 | 22.3 | 22.5 | 23.0 | 22.7 |
Taste, Nutrition & Health, EBITDA-margin (%) normalized* | Lowest | | | - | 20.9 | 21.5 | 21.6 | 21.6 | 22.0 |
Taste, Nutrition & Health, EBITDA reported | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Taste, Nutrition & Health, EBITDA reported | Highest | | | - | 688.0 | 776.8 | 863.1 | 955.5 | 1,059.9 |
Taste, Nutrition & Health, EBITDA reported | Consensus | - | 629.3 | - | 673.3 | 734.4 | 796.0 | 867.5 | 964.6 |
Taste, Nutrition & Health, EBITDA reported | Median | | | - | 673.1 | 735.0 | 790.0 | 869.1 | 938.4 |
Taste, Nutrition & Health, EBITDA reported | Lowest | | | - | 653.2 | 693.9 | 735.5 | 779.6 | 895.5 |
Taste, Nutrition & Health, EBITDA-margin (%) reported | Number of Estimates | | | - | 15 | 13 | 13 | 7 | 3 |
Taste, Nutrition & Health, EBITDA-margin (%) reported | Highest | | | - | 22.4 | 23.4 | 24.0 | 24.6 | 23.3 |
Taste, Nutrition & Health, EBITDA-margin (%) reported | Consensus | - | 21.1 | - | 21.8 | 22.3 | 22.6 | 22.9 | 22.7 |
Taste, Nutrition & Health, EBITDA-margin (%) reported | Median | | | - | 21.8 | 22.3 | 22.5 | 23.0 | 22.7 |
Taste, Nutrition & Health, EBITDA-margin (%) reported | Lowest | | | - | 20.9 | 21.5 | 21.6 | 21.6 | 22.0 |